Follow
Shada J. Alabed
Shada J. Alabed
Assistant professor of Medicinal chemistry and drug design at Al-Zaytoonah University of Jordan
Verified email at zuj.edu.jo
Title
Cited by
Cited by
Year
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
S Daoud, SJ Alabed, LA Dahabiyeh
Acta Pharmaceutica 71 (2), 163-174, 2021
302021
Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation
SJ Alabed, M Khanfar, MO Taha
Future medicinal chemistry 8 (15), 1841-1869, 2016
172016
Discovery of potent NEK2 inhibitors as potential anticancer agents using structure-based exploration of NEK2 pharmacophoric space coupled with QSAR analyses
MA Khanfar, F Banat, S Alabed, S Alqtaishat
Molecular diversity 21, 187-200, 2017
102017
Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning
SJ Alabed, M Zihlif, M Taha
RSC advances 12 (55), 35873-35895, 2022
52022
PHYTOCHEMICAL SCREENING AND CYTOTOXIC EVALUATION OF SALVIA GREGGII EXTRACTS: AN IN VITRO AND IN SILICO STUDY
N Aboalhaija, A Alsalman, S Alabed, W Talib, I Abaza, F Afifi
Farmacia 72 (1), 171-177, 2024
2024
Discovery of potent maternal embryonic leucine zipper kinase (MELK) inhibitors of novel chemotypes using structure-based pharmacophores
S Daoud, SJ Alabed, SK Bardaweel, MO Taha
Medicinal Chemistry Research 32 (12), 2574-2586, 2023
2023
Antiproliferative evaluation of the hydro-distilled oil of celery, coriander, dill, and fennel and chemometric analysis of their aroma profile
N Aboalhaija, AH Alsalman, S Alabed, I Abaza, A Mahmod, W Talib, F Afifi
Journal of Essential Oil Bearing Plants 26 (6), 1487-1501, 2023
2023
Asenapine as a Potential Lead Inhibitor against Central Ca/Calmodulin-Dependent Protein Kinase II: Investigation by Docking Simulation and Experimental Validation
S Daoud, R Abutayeh, SJ Alabed, MO Taha
The Open Medicinal Chemistry Journal 17 (1), 2023
2023
Asenapine as a Potential Lead Inhibitor against Central Ca2+/Calmodulin-Dependent Protein Kinase II: Investigation by Docking Simulation and Experimental Validation
S Daoud, R Abutayeh, SJ Alabed, MO Taha
The system can't perform the operation now. Try again later.
Articles 1–9